forecasting
agent
← back to scans

Above 20000 Cyclosporiasis cases in the United States during 2026 — Above 20k

kalshiScience and Technology·2026-10-01·view on kalshi ↗
93%
Agent
92%
Market Price
+1.2%
Edge
78%
Confidence
14,249
Volume
5.0c
Spread
91
Days to resolution
15
Markets in event
final rationale
Mean of 5 draws (0.93, 0.93, 0.93, 0.93, 0.94). (0) Not yet documented above 20k: CDC's dedicated case-data page (Sept 15) shows 19,883 lab-confirmed domestic cases for May 1–Aug 31, with 2,078 travel cases, 9,765 confirmed cases pending domestic/travel classification, and 6,594+ more unconfirmed. Crossing requires a CDC/NNDSS update before Jan 8. (a) About 3 months remain to the Jan 8, 2027 check, and backdated 2026 cases count. (b) Status quo: the domestic-only snapshot sits just 117 under, but CDC said it would keep updating periodically. Even small conversion of the pending pool, or any count including travel (21,961) or the full calendar year, clears it. NNDSS year tables ran well above the season count in 2025 (3,952 vs 1,180), and state tallies exceed 33k. (c) NO: CDC never refreshes the domestic page before Jan 8, the binding source is that frozen 19,883, or reconciliation trims the count. (d) YES: a periodic CDC update or the NNDSS cumulative table shows pending cases converted, well past 20k. The market anchor of 92–97% is consistent; residual risk is source and update ambiguity.
price vs. prediction
market price agent forecast at t+0
17 follow-ups
1. Planner Opus 5.5 · picks the research tools
Tools chosen: kalshi_direct resolution_source kalshi_related article_search wikipedia
Planner reasoning
Kalshi market on 2026 US cyclosporiasis case counts. The anchors are the market's own price and the resolution source, CDC NNDSS weekly tables, which give year-to-date cumulative counts. Related Kalshi markets in the same series and Wikipedia background on historical annual case counts help set the base rate. One targeted article search covers the latest CDC year-to-date total and any 2026 outbreaks.
2. Research parallel tool calls + 4 web research loops (Sonnet 5) · read raw by the forecasters
at a glance
RESEARCH DIGEST (built in code: tool summaries and each report's bottom line; the forecasters read the full tool outputs and reports) Tools - kalshi_direct: ## This Market's Kalshi Data **Above 20k** (KXCYCLOCOUNT-27JAN01-A20000) - Current price (probability): 92.00% (live; bid 92% / ask 97%) - Last daily close (2026-10-01): 97.00% - 7-day price change: -1.00% - 30-day price change: +11.00% - Average daily volume: 285 contracts - Price range: 12.00% - 98.00% - Data points: 50 days - resolution_source: already_resolved=unclear; matches_criteria=False; last_updated=September 11, 2026. The page lists outbreak investigations and only mentions a 'Cyclospora Outbreak Linked to Iceberg Lettuce' that 'recently ended' as of Sept 11, 2026, with no case counts or totals for 2026 provided. - kalshi_related: 0 related markets / summaries. series KXCYCLOCOUNT: 0 markets (skipped 15 no-signal) | keyword 'cyclosporiasis': no matches - article_search: Fetched 10 unique articles across 2 queries (lookback=90d). 'CDC cyclosporiasis 2026 domestically acquired cases count': 8 articles | 'cyclospora outbreak 2026 cases reported': 8 articles - wikipedia: Fetched 1 Wikipedia entries (0 missing pages). Research loops, bottom lines - current state: On CDC's own dedicated Cyclospora surveillance page — the most authoritative, up-to-date tracker — domestically acquired lab-confirmed cases for the 2026 season already stood at 19,883 as of Sept 15, 2026 (plus 2,078 travel-acquired, and thousands more pending confirmation), meaning the 20,000 threshold for "cyclosporiasis cases reported in the United States during 2026" has very likely already been crossed or is essentially guaranteed to be crossed once pending cases are finalized before the Ja - base rate: Historically (2016–2025), annual U.S. cyclosporiasis case counts never approached 20,000 — typical years saw roughly 1,000–4,700 confirmed cases, making a "Yes" outcome a near-impossible base-rate event in any ordinary year. However, 2026 is a massive historical outlier: confirmed cases already stand at ~19,883 (plus ~9,765 pending confirmation and ~6,594 more unconfirmed) as of mid-September, so unlike the long-run base rate, the specific 2026 season has very likely already crossed 20,000 even - yes case: On CDC's own dedicated, most-current Cyclospora surveillance page, reported cases for 2026 already stand at 19,883 domestic-only (and 21,961 if travel-acquired cases reported to the same U.S. system are included), with CDC explicitly flagging roughly 16,000 additional cases in its pending/unconfirmed pipeline and an active ~6-week reporting lag still adding confirmed cases weeks after the "season" ended — making a final 2026 total above 20,000 the single most probable outcome on essentially any - no case: The only clean, dated, officially confirmed CDC national figure (19,883 as of Sept. 15) sits just under 20,000, CDC has stopped its weekly cadence citing a "significant decline" in new infections, state-level data (NC) show new reports have nearly stopped, and CDC's own methodology explicitly excludes the thousands of "pending"/"probable" cases that would be needed to close the gap — all of which argue that the strict, officially-confirmed 2026 domestic total may never be affirmatively reported
tools
toolstatustimeitemssummary
kalshi_direct OK 0.2s 1 ## This Market's Kalshi Data **Above 20k** (KXCYCLOCOUNT-27JAN01-A20000) - Current price (probability): 92.00% (live; bid 92% / ask 97%) - Last daily close (2026-10-01): 97.00% - 7-day price change: -1.00% - 30-day price change: +11.00% - Average daily volume: 285 contracts - Price range: 12.00% -
resolution_source OK 4.6s 1 already_resolved=unclear; matches_criteria=False; last_updated=September 11, 2026. The page lists outbreak investigations and only mentions a 'Cyclospora Outbreak Linked to Iceberg Lettuce' that 'recently ended' as of Sept 11, 2026, with no case counts or totals for 2026 provided.
kalshi_related OK 0.6s 0 0 related markets / summaries. series KXCYCLOCOUNT: 0 markets (skipped 15 no-signal) | keyword 'cyclosporiasis': no matches
article_search OK 0.4s 10 Fetched 10 unique articles across 2 queries (lookback=90d). 'CDC cyclosporiasis 2026 domestically acquired cases count': 8 articles | 'cyclospora outbreak 2026 cases reported': 8 articles
wikipedia OK 0.3s 1 Fetched 1 Wikipedia entries (0 missing pages).
research loops · 4/4 ok · 15 searches · 6 page reads
dimensionstatustimesearchespage readsreport
current state OK 41s 4 2 5679 chars
base rate OK 27s 3 1 4135 chars
yes case OK 51s 3 2 5570 chars
no case OK 70s 5 1 5466 chars
report: current state
- [2026-01-05] CDC's year-end surveillance snapshot for the prior (2025) season showed 2025 cases acquired in the United States: 1,180, with 105 hospitalizations and no deaths, reported by 37-38 states — the baseline the 2026 season has been compared against. https://www.cdc.gov/cyclosporiasis/php/surveillance - [2026-07-13] CDC issued a Health Alert Network notice stating since May 1, 2026, CDC had received reports of 1,645 confirmed domestic cases of cyclosporiasis and was aware of more than 5,100 cases requiring further analysis , already substantially higher than the 249 cases reported nationally by this same time last year . https://www.cdc.gov/han/php/notices/han00531.html - [2026-07-16] A large cluster was linked to food: the CDC announced an outbreak associated with consumption of lettuce served at Taco Bell stores in Indiana, Kentucky, Michigan, Ohio and West Virginia that sickened more than 1,644 people . https://doh.wa.gov/you-and-your-family/illness-and-disease-z/foodborne-illness/outbreaks/2026-cyclosporiasis-outbreak - [2026-08-05] CDC's official surveillance page updated to show May 1–August 3, 2026: 10,468 laboratory-confirmed U.S.-acquired cases, 517 hospitalizations, 2 deaths, 47 states reporting , with more than 12,255 additional cases not yet lab-confirmed or requiring further investigation . https://www.cdc.gov/cyclosporiasis/php/surveillance/index.html - [2026-08-12] ABC News reported that combining confirmed and pending cases, cases of cyclosporiasis topped 24,000 according to CDC data, with at least 13,895 laboratory-confirmed cases (740 hospitalizations) and at least 10,455 additional cases not yet laboratory confirmed , though the rate of increase appeared to have slowed, with only about 2,000 more cases recorded over the last week . https://abcnews.com/Health/24000-cyclosporiasis-infections-reported-new-cases-slow-cdc/story?id=135514625 - [2026-08-26] Case counts continued climbing: since May 1, 2026, CDC had received reports of 17,180 laboratory-confirmed cases of cyclosporiasis acquired in the U.S., resulting in 922 hospitalizations and two deaths . https://www.food-safety.com/articles/11627-cdc-reports-up-to-7-000-cyclosporiasis-cases-across-us-identifies-large-midwestern-outbreak-cluster - [2026-09-11] CDC formally declared the Taylor Farms lettuce-linked outbreak over, with a final total of 12,883 illnesses across 21 states, at least 570 hospitalizations and two deaths (both in Michigan) , this being one subcluster within the broader national case count. https://foodpoisoningbulletin.com/2026-cyclospora-outbreak/ - [2026-09-15] CDC's dedicated "Cyclospora Case Data" page (last updated/reviewed Sept 15, 2026) reports for the full 2026 season (May 1–Aug 31): "Since May 1, 2026, CDC has received reports of 19,883 laboratory-confirmed cases of cyclosporiasis acquired in the United States," with 1,064 hospitalizations and 2 deaths across 49 states plus DC; it also separately lists 2,078 lab-confirmed travel-acquired cases outside the U.S. in the same window. It further notes 9,765 additional cases pending domestic/travel classification and at least 6,594 more not yet lab-confirmed or pending submission. https://www.cdc.gov/cyclosporiasis/cases/index.html - [2026-09-15] CDC announced it will stop weekly updates to this page: "As of September 15, CDC will stop updating this page weekly because the number of recent infections has significantly declined," while planning periodic updates going forward. https://www.cdc.gov/cyclosporiasis/cases/index.html - [2026-09-30] A roundup piece (dated 2 days before today) summarized the season's final domestic tally as "nearly 20,000," stating the CDC reported 19,883 confirmed cases of cyclosporiasis acquired in the US between May and August 2026, compared with 1,180 during the same period in 2025, with 1,064 hospitalizations and two deaths, in 49 states and DC . https://www.mundonow.com/en/us-food-recalls-cyclospora-outbreak-cheese-and-meat-alerts/ - [2026-01-03 week] Separately, CDC's formal Nationally Notifiable Diseases Surveillance System (NNDSS) weekly table — a different, typically lower and lagged, official tabulation — showed cumulative YTD 2025 cyclosporiasis cases of only 3,952 nationally as of the week ending Jan 3, 2026, illustrating that the NNDSS "Cum YTD" channel runs well below the dedicated outbreak-surveillance page's totals and could matter if it is the designated "Source Agency" table for resolution. https://stacks.cdc.gov/view/cdc/251467/cdc_251467_DS1.pdf BOTTOM LINE: On CDC's own dedicated Cyclospora surveillance page — the most authoritative, up-to-date tracker — domestically acquired lab-confirmed cases for the 2026 season already stood at 19,883 as of Sept 15, 2026 (plus 2,078 travel-acquired, and thousands more pending confirmation), meaning the 20,000 threshold for "cyclosporiasis cases reported in the United States during 2026" has very likely already been crossed or is essentially guaranteed to be crossed once pending cases are finalized before the Jan 8 expiration; the only caveat is if resolution instead keys strictly to the slower, lower NNDSS weekly tabulation rather than this outbreak-specific count. NOT FOUND: No official CDC or NNDSS update dated after Sept 15, 2026 giving a newer cumulative national total; no explicit statement from Kalshi/the market's rules clarifying which exact "Source Agency" table (dedicated Cyclospora page vs. NNDSS weekly table vs. combined domestic+international) governs final resolution; no post-September confirmation of how many of the ~9,765 "pending analysis" cases were ultimately classified as domestic vs. international.
report: base rate
- [2026-09-15] CDC's official case-data page reports since May 1, 2026, CDC has received reports of 19,883 laboratory-confirmed cases of cyclosporiasis acquired in the United States with symptom onset dates during the 2026 cyclosporiasis season (May 1–August 31, 2026) , already near the 20,000 threshold from confirmed cases alone, with thousands more pending confirmation. - [2026-09-15] The same page notes For comparison, 1,180 cases were reported in the United States between May 1 and August 31, 2025 , and separately records 9,765 additional cases under investigation for domestic/travel status plus 6,594 more not yet lab-confirmed, implying a much higher eventual total once reporting lag (~6 weeks) resolves. - [2024 report, cited 2026-07] Historical annual lab-confirmed totals were far below 20,000: per Food Safety Magazine/CDC-derived reporting, Between 2019 and 2022, the number of laboratory-confirmed cases of cyclosporiasis in the U.S. ranged from a high in 2019 of 2,408 cases to a low in 2021 of 1,024 cases. By 2023, there were nearly 3,000 cases of cyclosporiasis reported in the U.S. - [2026-07-21] CNN reported federal officials' figures showing more than 4,500 cases in 2023 and more than 3,500 cases in 2024 — both well under the 20,000 threshold, underscoring that 2026 is an extreme outlier year. - [2016-2019 trend, consumerreports.org] Longer-term base rate shows steady pre-pandemic growth: cases of cyclospora have been steadily increasing over the past decade. According to CDC data, there were 537 cases In 2016, and by 2023 (the latest data available), the number of cases had increased to 4,463. - [2026-07-16, NBC News] A CDC official characterized typical annual case volume as roughly 2,700, far below 20,000: There are usually about 2,700 cases each year, mostly during the summer months. - [2026-07] On historical outbreak size, CNN cited USDA/FSIS reporting that the largest cyclospora outbreak in the US on record led to about 1,500 cases and involved raspberries. Other large outbreaks typically haven't surpassed 1,000 cases — meaning 2026's Midwest outbreak (6,000+ linked cases) is unprecedented relative to all prior outbreaks. - [2026-07-21] CNN described this year's outbreak as historically unique: With nearly 2,000 cases linked to the current outbreak centered in the Midwest, it is the largest known cyclospora outbreak in the US to date. - [2026-09 approx, genomicepi.com] Aggregated CDC/NORS outbreak data from 1990–2023 show cyclosporiasis outbreaks have historically been small in cumulative scale: The publicly available CDC's National Outbreak Reporting System (NORS) data file includes 181 outbreak records from 1990 through 2023, totaling 6,251 illnesses and 198 hospitalizations. That is less than one-third of the single 2026 season's confirmed count. - [2026-09-15] State-level anecdote underscoring the scale of deviation from base rate: Michigan, which typically reports around 50 cases per year , has reported over 12,000 cases in 2026 per Food Safety Magazine reporting of state data. - [2026-01-05, CDC] The prior full season (2025) ended well below the 20k threshold: As of January 5, 2026, 1,180 cases of cyclosporiasis acquired in the United States had been reported to CDC... Cases were reported by 38 states. BOTTOM LINE: Historically (2016–2025), annual U.S. cyclosporiasis case counts never approached 20,000 — typical years saw roughly 1,000–4,700 confirmed cases, making a "Yes" outcome a near-impossible base-rate event in any ordinary year. However, 2026 is a massive historical outlier: confirmed cases already stand at ~19,883 (plus ~9,765 pending confirmation and ~6,594 more unconfirmed) as of mid-September, so unlike the long-run base rate, the specific 2026 season has very likely already crossed 20,000 even before backdated reports from the ~6-week lag are fully tallied. NOT FOUND: An official CDC final/finalized annual tally for 2026 (the NNDSS "final" dataset, typically published well into the following year) was not available; nor was a specific post-September update beyond the Sept. 15, 2026 CDC case-data snapshot.
report: yes case
YES means: CDC's reported tally of cyclosporiasis cases in the United States during 2026 ends up above 20,000 — i.e., the 2026 season's case count (as tabulated by CDC's dedicated surveillance system, the "Source Agency" table) exceeds 20,000 once finalized by the Jan 8 expiration. - [2026-09-15] On its authoritative, most-recently-updated tracker, CDC states "Since May 1, 2026, 19,883 people have been reported with laboratory-confirmed cyclosporiasis acquired in the United States" , and separately for travel-acquired illness, the CDC confirms additional lab-confirmed cases acquired outside the U.S. in the same window — specifically 2,078 travel-associated lab-confirmed cases with 74 hospitalizations. Domestic-plus-travel confirmed cases reported to CDC already total 21,961, above 20,000, if "cases reported in the United States" is read to include all cases reported into the U.S. national system rather than only domestically-acquired illness. - [2026-09-15] Even restricting to domestically-acquired cases alone, CDC is withholding a further large buffer of near-certain additions: "There were 9,765 laboratory-confirmed cases of cyclosporiasis reported to CDC requiring further investigation to determine whether they were acquired in the United States or during travel. CDC is aware of at least 6,594 additional cases of cyclosporiasis, which include those that were not laboratory confirmed, or were pending patient interview and submission to CDC." Historically the large majority of such "pending" cases in this outbreak have been classified domestic, so even a modest confirmation rate on the 9,765 pending pool alone would push the domestic total well past 20,000. - [2026-09-18] Independent tracking (Marler Blog, compiling CDC's own page) confirms the pending pool, not CDC's confirmed count, is still the only thing separating the season from a vastly larger total: "Underneath the confirmed 19,883, CDC has 9,765 laboratory-confirmed cases still being sorted into domestic or travel-acquired and at least 6,594 more that are not laboratory confirmed or are awaiting an interview" , with travel-associated cases reported separately at 2,078. - [2026-09-20] A food-safety legal tracker (citing CDC's prior weekly release) shows the growth trajectory and scale of the "dark" pool explicitly: "Add the three categories together and CDC is aware of 35,099 cyclosporiasis cases this season." Even if only ~15% of that 35,099 aggregate is ultimately confirmed domestic beyond the already-counted 19,883, the 20,000 threshold is cleared. - [2026-09-21] Medical Daily (citing CDC data) documents that the domestic count kept climbing even after the official season "ended" August 31 and after the outbreak was declared over: "Since then, the domestic total has grown by 288 cases, and the agency has moved from weekly to occasional reporting." This confirms CDC's own stated mechanism — a ~6-week lag between symptom onset and reporting — is still actively adding new confirmed cases to the 2026 tally as of late September, with CDC itself cautioning "CDC warns that the season's unprecedented volume means earlier cases may keep arriving past that window." - [2026-09-29] A roundup piece two days before today reconfirms the season's running total is "nearly 20,000" but static at the Sept 15 CDC snapshot (19,883), with no newer official figure yet published — meaning the next CDC "periodic update" (rather than another weekly release) is the likely trigger that will push the publicly reported figure visibly over 20,000. - [2026-09-17] FDA's own outbreak page, syndicated via Carrier Management, corroborates that new cases kept being added to the outbreak subtotal through at least mid-September: "Since the last update on August 27, 2026, state and local health officials have continued to interview additional sick people with Cyclosporiasis and the CDC has added them to this multi-state outbreak." This is one concrete, ongoing channel (not the only one) by which the 9,765 "pending" pool continues to convert into confirmed domestic cases. - [2026-09-15] CDC's rules for its own page explicitly anticipate further growth of the official 2026 total, not a freeze: "CDC updated its Cyclospora case-data page on September 15, 2026, and said it was the last weekly one." It shifted only the update cadence (to periodic), not the counting methodology — meaning any future CDC release (which must occur before the Jan 8 expiration given the question's own backdating rule) will simply reflect further accretion from the already-identified pending pool. BOTTOM LINE: On CDC's own dedicated, most-current Cyclospora surveillance page, reported cases for 2026 already stand at 19,883 domestic-only (and 21,961 if travel-acquired cases reported to the same U.S. system are included), with CDC explicitly flagging roughly 16,000 additional cases in its pending/unconfirmed pipeline and an active ~6-week reporting lag still adding confirmed cases weeks after the "season" ended — making a final 2026 total above 20,000 the single most probable outcome on essentially any reasonable reading of "cases reported in the United States during 2026." NOT FOUND: No CDC update newer than September 15, 2026 giving a revised cumulative total (CDC has moved to "periodic" updates only); no explicit confirmation of how many of the 9,765 pending-classification cases have since been resolved as domestic versus travel; no clarification of exactly which CDC/NNDSS table Kalshi's rules designate as the binding "Source Agency" for final resolution.
report: no case
YES means: CDC (or whichever official source governs resolution) confirms that more than 20,000 cyclosporiasis cases were reported in the United States during 2026; NO means the official reported count for 2026 stays at or below 20,000 by the time the market is settled. - [2026-09-15] CDC's own dedicated case-data page states the 19,883 lab-confirmed figure covers only "cases with symptom onset dates during the 2026 cyclosporiasis season (May 1–August 31, 2026)" — a defined sub-period, not the full calendar year the contract title references — and that figure is still below the 20,000 strike. https://www.cdc.gov/cyclosporiasis/cases/index.html - [2026-09-15] CDC explicitly announced it will stop weekly updates to this tracker "because the number of recent infections has significantly declined," switching to unspecified "periodic" updates, which removes the cadence that had been pushing the count upward each week and creates real risk that no further authoritative update crosses the line before the Jan 8 resolution check. https://www.cdc.gov/cyclosporiasis/cases/index.html - [2026-09-10/11] Food Safety News reported the confirmed national total at that point was 19,595 lab-confirmed domestic cases — still under 20,000 even after the entire outbreak season had concluded on Aug. 31 — while separately noting "the CDC is aware of 6,149 additional cases of cyclosporiasis, which include those that are not laboratory confirmed, or are pending patient interview and submission," underscoring that a large share of the "extra" cases CDC is "aware of" are explicitly not yet confirmed. https://www.foodsafetynews.com/2026/09/cdc-reporting-almost-20-000-confirmed-patients-in-cyclospora-outbreak/ - [2026-09-10/11] The same report shows a stark divergence between CDC's strict confirmed count and raw state tallies: "States are keeping their own tallies, with the total now standing at 33,548 cases this season," while explicitly noting that unlike states (some of which count by calendar year and "include probable cases and cases still pending classification"), "The CDC excludes both" — i.e., CDC's official national number, the most likely resolution source, deliberately strips out exactly the kind of pending/probable cases that would be needed to push the total convincingly past 20,000. https://www.foodsafetynews.com/2026/09/cdc-reporting-almost-20-000-confirmed-patients-in-cyclospora-outbreak/ - [2026-09-15 to present] North Carolina's state dashboard — one of the few jurisdictions still publishing after the national page went dark — shows the curve has essentially flatlined: "955 Cases Since May 2026" with only "3 Newly Reported Cases" logged "Since Sept. 15 update," and the state's own page notes "Cases began trending down at the end of August 2026," suggesting the nationwide backlog-to-confirmed conversion rate that would be needed to add ~120+ more cases nationally (let alone thousands) has slowed to a trickle. https://www.dph.ncdhhs.gov/programs/epidemiology/communicable-disease/foodborne-illnesses/cyclosporiasis/cases - [2026-10 search] No post-September-15 CDC update, HAN notice, or major news report could be found explicitly stating that the national lab-confirmed domestic count has crossed 20,000; the most recent authoritative figure located remains the Sept. 15 snapshot of 19,883, meaning no confirmed source yet shows the threshold breached. - [general] CDC's own NNDSS methodology notes caution against assuming monotonic increases: cumulative counts "may increase or decrease as updates occur" and "finalized annual data often differ from provisional counts," leaving open the possibility that final reconciliation (removing duplicates, reclassifying travel-linked or probable cases) nets the confirmed domestic total down rather than further up. https://stacks.cdc.gov/view/cdc/174365 - [structural] The CDC page's own case definition draws a hard line between "Cases acquired in the U.S." (19,883) and "Cases acquired outside the U.S." (2,078, explicitly labeled as being "in addition to" the domestic figure), so if resolution hinges on the CDC's primary domestic figure rather than a combined total, the operative number sits roughly 117 cases shy of 20,000 as of the last confirmed snapshot, with no mechanism confirmed to guarantee it crosses before expiration. https://www.cdc.gov/cyclosporiasis/cases/index.html BOTTOM LINE: The only clean, dated, officially confirmed CDC national figure (19,883 as of Sept. 15) sits just under 20,000, CDC has stopped its weekly cadence citing a "significant decline" in new infections, state-level data (NC) show new reports have nearly stopped, and CDC's own methodology explicitly excludes the thousands of "pending"/"probable" cases that would be needed to close the gap — all of which argue that the strict, officially-confirmed 2026 domestic total may never be affirmatively reported above 20,000 before the Jan 8 resolution check, even though informal "aware of" totals (confirmed + pending) already exceed it. NOT FOUND: Any CDC/NNDSS update dated after September 15, 2026 with a new national cumulative figure; any explicit Kalshi rule text specifying which exact CDC table/page is the binding "Source Agency" dataset (dedicated outbreak page vs. NNDSS Table 1I vs. a combined domestic+travel total); confirmation of how many of the ~16,000 pending/unconfirmed cases noted in September were ultimately lab-confirmed as domestic by late September or October.
3. Forecasters 5 draws · Opus 5.5 + GPT-5.6 Sol · plain mean
claude-opus-5-5
80% conf
Yes 93%
No 7%
(0) Not yet documented above 20k: CDC's dedicated case-data page (Sept 15) shows 19,883 lab-confirmed domestic cases for May 1–Aug 31, with 2,078 travel cases, 9,765 confirmed cases pending domestic/travel classification, and 6,594+ more unconfirmed. Crossing requires a CDC/NNDSS update before Jan 8. (a) About 3 months remain to the Jan 8, 2027 check, and backdated 2026 cases count. (b) Status quo: the domestic-only snapshot sits just 117 under, but CDC said it would keep updating periodically. Even small conversion of the pending pool, or any count including travel (21,961) or the full calendar year, clears it. NNDSS year tables ran well above the season count in 2025 (3,952 vs 1,180), and state tallies exceed 33k. (c) NO: CDC never refreshes the domestic page before Jan 8, the binding source is that frozen 19,883, or reconciliation trims the count. (d) YES: a periodic CDC update or the NNDSS cumulative table shows pending cases converted, well past 20k. The market anchor of 92–97% is consistent; residual risk is source and update ambiguity.
claude-opus-5-5
78% conf
Yes 93%
No 7%
(0) Not yet clearly met: CDC's Sept 15 Case Data page shows 19,883 lab-confirmed domestic cases, 117 short of 20,000. The same page shows 2,078 travel-acquired cases (21,961 combined), 9,765 confirmed cases pending classification and 6,594+ unconfirmed. A Sept 21 Medical Daily report cites 288 further domestic additions, though its baseline is unclear. (a) About 3 months remain; resolution reads the source at 10 AM ET on Jan 8, 2027, and backdated 2026 cases count. (b) Status quo: if CDC never updates and only the domestic-only figure is used, it stays at 19,883 (NO). That is unlikely given CDC's promised periodic updates, the huge pending pool versus a 117-case gap, and NNDSS cumulative counts that historically run well above the dedicated page (3,952 vs 1,180 for 2025). (c) NO: the domestic-only page is the source, CDC issues no update before Jan 8, or reconciliation trims the count. (d) YES: any periodic CDC update, NNDSS cumulative total, or combined domestic-plus-travel count exceeds 20,000. I anchor near the Kalshi 92-97% range and keep some residual risk for source ambiguity.
claude-opus-5-5
80% conf
Yes 93%
No 7%
(0) CDC's Sept 15 Case Data page shows 19,883 domestic lab-confirmed cases, ~117 short of 20k, plus 2,078 travel-acquired (21,961 combined) and 9,765 lab-confirmed cases pending classification. Medical Daily (Sept 21) cites +288 further domestic growth, so the threshold may already be crossed. (a) About 3 months remain until the Jan 8 determination; CDC has moved to 'periodic' updates and will very likely revise before then. NNDSS tables, which historically run higher than domestic-only counts, would likely also exceed 20k. (b) Status quo: the published domestic figure sits just under 20k, but backdated pending cases almost certainly push it over on the next update. (c) NO: CDC does not update before Jan 8, Kalshi keys strictly to domestic-only 19,883, and NNDSS lags or reclassifies below 20k. (d) YES: the next periodic CDC update shows >20k domestic, or the source counts travel-acquired cases or uses NNDSS totals. The market at 92-97% is consistent with this; I hold slightly below the midpoint for update-cadence and source-selection risk.
gpt-5.6-sol
77% conf
Yes 93%
No 7%
(0) The resolving condition is not yet conclusively met: CDC’s September 15 case-data page reports 19,883 laboratory-confirmed domestically acquired cases, 117 short of 20,000, while the available resolution-source read does not provide a usable numeric total. (a) About 99 days remain until the January 8 resolution check, including a post-2026 window in which newly reported cases backdated to 2026 count. (b) If nothing changes in the official domestic tally, the market resolves No because 19,883 is not above 20,000. (c) No could also result if CDC publishes no further update before expiration, pending cases are mostly excluded or reclassified, or Kalshi uses the materially lower NNDSS tabulation rather than the dedicated case-data page. (d) Yes requires only 118 additional confirmed domestic cases, and CDC had 9,765 laboratory-confirmed cases awaiting domestic-versus-travel classification plus thousands more under review, making that increment highly likely despite declining incidence. I anchor on Kalshi’s 92% current Yes price and move slightly higher to 93% because the tiny remaining gap and substantial documented backlog outweigh the unresolved source-definition and update-cadence risks.
gpt-5.6-sol
74% conf
Yes 94%
No 6%
(0) The condition is not yet documented as met: CDC’s September 15 case-data page reports 19,883 laboratory-confirmed domestically acquired cases, 117 short of 20,000, while the supplied resolution-source read reached an outbreak summary rather than the numeric surveillance page. (a) About 99 days remain from October 1 until the January 8, 2027 determination, during which newly reported cases backdated to 2026 count. (b) If the official figure never changes, the market resolves No because 19,883 is not above 20,000. (c) No results if CDC publishes no further qualifying update before determination, pending cases are excluded or reclassified, or Kalshi uses the substantially lower NNDSS tabulation rather than the dedicated case-data page. (d) Yes requires only 118 additional domestic confirmations, and CDC already lists 9,765 laboratory-confirmed cases pending domestic-versus-travel classification plus thousands more pending confirmation, while the domestic total reportedly grew by 288 even after August 31. I price Yes at 94%, modestly above Kalshi’s 92% current price but within its 92%–97% spread, because the small remaining numerical gap and large backlog outweigh the meaningful unresolved-source and publication-cadence risks.
4. Final plain mean of 5 draws
93% (78% confidence)
Yes: 93% No: 7%
Mean of 5 draws (0.93, 0.93, 0.93, 0.93, 0.94). (0) Not yet documented above 20k: CDC's dedicated case-data page (Sept 15) shows 19,883 lab-confirmed domestic cases for May 1–Aug 31, with 2,078 travel cases, 9,765 confirmed cases pending domestic/travel classification, and 6,594+ more unconfirmed. Crossing requires a CDC/NNDSS update before Jan 8. (a) About 3 months remain to the Jan 8, 2027 check, and backdated 2026 cases count. (b) Status quo: the domestic-only snapshot sits just 117 under, but CDC said it would keep updating periodically. Even small conversion of the pending pool, or any count including travel (21,961) or the full calendar year, clears it. NNDSS year tables ran well above the season count in 2025 (3,952 vs 1,180), and state tallies exceed 33k. (c) NO: CDC never refreshes the domestic page before Jan 8, the binding source is that frozen 19,883, or reconciliation trims the count. (d) YES: a periodic CDC update or the NNDSS cumulative table shows pending cases converted, well past 20k. The market anchor of 92–97% is consistent; residual risk is source and update ambiguity.
Pipeline Timing
Total pipeline time: 132.3s
Per-tool research timings shown in the Research section above.